Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dual Channel of Time-Coded Fluorescence Materials Constructed by Europium-Dynamic Covalent Surfactant and Carbon Quantum Dots for Information Encryption.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Anti-Inflammatory Cytokine Signatures in Primary Glaucoma Subtypes: Diagnostic and Pathophysiological Insights From IL-36Ra, IL-37, and IL-38.

Journal of ophthalmology·2026
Same author

Caregiver guilt as an underrecognised burden in family cancer caregiving: a scoping review and implications for palliative care support.

BMC palliative care·2026
Same author

Breathing new life into T-cell receptor-engineered T-cell therapy in solid tumors: enhancing strategies to expand the universality of precision therapy.

Experimental hematology & oncology·2026
Same author

Smart Pickering Emulsions Co-Stabilized by Chalcogenoviologen Surfactants and Single-Atom Pt-Decorated g-C<sub>3</sub>N<sub>4</sub> for Switchable Biphasic Photocatalysis†.

Journal of the American Chemical Society·2026
Same author

Spatial distribution of per- and polyfluoroalkyl substances in the Yellow River basin: Role of suspended sediment on the PFAS partition and accumulation.

Journal of hazardous materials·2026
Same journal

KIAA0101 in human cancers: From biomarker discovery to therapeutic targeting.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Senescence in non-cancerous cells within the tumor: What is the real deal?

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

The MYC network: Hub of malignancy and blueprint for intervention.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Organoid-based platforms for oncolytic virus discovery and optimization: Bridging in vitro innovation and clinical translation.

Biochimica et biophysica acta. Reviews on cancer·2026
查看所有相关文章

相关实验视频

Updated: Mar 9, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.1K

重编程MDSC中的铁亡:对于状态依赖的免疫疗法组合.

Yawen Li1, Yuguang Zhao1

  • 1Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

Biochimica et biophysica acta. Reviews on cancer
|March 7, 2026
PubMed
概括
此摘要是机器生成的。

向髓质衍生抑制细胞 (MDSCs) 中的铁亡可以调节抗瘤免疫力. 策略包括在次致命压力期间限制免疫抑制媒介或诱导致命的铁亡,以增强免疫激活和免疫疗法协同作用.

关键词:
铁化是铁化的一种.铁灭菌免疫调节窗口免疫抑制是一种免疫抑制.在MDSCs中.瘤免疫疗法免疫疗法

更多相关视频

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.7K

相关实验视频

Last Updated: Mar 9, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.1K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.7K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 细胞死亡机制 细胞死亡机制

背景情况:

  • 骨髓系衍生抑制细胞 (MDSCs) 在瘤免疫逃避中发挥着关键作用.
  • 铁亡是一种受调节的细胞死亡形式,影响MDSC功能和抗瘤免疫力.
  • 由MDSC介导的免疫抑制是取决于情境的,并受到ferroptotic压力的影响.

研究的目的:

  • 审查MDSC铁化在调节抗瘤免疫力的作用.
  • 为治疗向引入"ferroptosis免疫调节窗口"概念.
  • 探索调节MDSC铁灭菌的策略,以增强癌症免疫治疗.

主要方法:

  • 审查现有的关于铁亡,MDSCs和抗瘤免疫的文献.
  • 分析影响MDSC铁亡的代谢途径 (ACOD1-伊他康酸-NRF2,ASAH2).
  • 开发治疗干预的概念框架.

主要成果:

  • 在MDSC中,亚致命性铁亡释放出免疫抑制媒介 (PGE2,氧化脂),抑制抗瘤T细胞和NK细胞功能.
  • 破坏特定的代谢途径使MDSC对铁灭症敏感.
  • 抑制ASAH2会诱导MDSC中的致命性铁亡,增强免疫活性.

结论:

  • "ferroptosis免疫调节窗口"提供了一种双重策略:限制免疫抑制媒介或诱导致命的ferroptosis.
  • 向MDSC铁死可以克服免疫抑制,并与免疫疗法协同作用.
  • 对有针对性的传递系统进行进一步的研究是必要的,以控制MDSC铁亡.